IN-VITRO GENERATION OF FULLY HUMAN

MONOCLONAL ANTIBODIES

As a biologics, therapeutics antibodies offer a significant margin of safety over conventional drugs. Over the past decade, the importance of fully human monoclonal antibodies as therapeutics for human diseases has been firmly established.

TM3 has created a proprietary technology called InVitrom Ab, for the in vitro generation of fully human monoclonal antibodies targeting virtually unlimited diseases. Our proof-of-concept experiments have proved the utility of the InVitromAb technology.

While the R&D is in its infancy, we believe the technology has enormous potential to enhance the use of monoclonal antibodies as therapeutics.

TM3 also offers our expertise and capabilities as a service for your <a href="rn We can guarantee you outstanding service, with unmatched prices.